Article, see p 1568 T he universe of acute stroke management went through a major shift at the beginning of 2015 when five randomized trials virtually simultaneously reported similar results showing that endovascular thrombectomy (EVT) dramatically reduced disability after acute ischemic stroke caused by intracranial large vessel occlusion. [1] [2] [3] [4] [5] These are the worst strokes that most often do not respond to systemic thrombolytics. The number needed to treat to result in one additional patient with no residual disability was only 4. Endovascular treatment was started within 6 hours of stroke symptom onset, but as with systemic thrombolysis and most reperfusion therapies, outcomes were better with faster achievement of successful reperfusion. Specialty societies and their guidelines almost immediately adopted EVT as standard of care. 6 In 2018, additional studies showed that some patients with adequate collaterals as identified on tissue/perfusion computed tomography or magnetic resonance imaging can benefit from EVT up to 24 hours after stroke symptom onset. 7, 8 The dual accomplishment of establishing a powerful new treatment and expanding the time window for its application to more patients has galvanized the stroke community. However, it has also created some problems, the main one being that the interventionalists and hospitals trained and equipped to identify good candidates and carry out EVT are largely limited to tertiary centers in urban areas. This is important, as for example, almost half of the US population does not live within a 60-minute drive of such a tertiary center 9 and must be transferred from another center. This issue, ie, getting patients eligible for EVT to the right hospital, is the broad topic addressed by the important study by Shah et al 10 published in this issue of Circulation. Using the Get With The Guidelines database, the authors found that since 2012, 43% of patients receiving EVT arrived by transfer from another hospital, with a sharp increase after 2015 when results from the 5 trials demonstrating EVT effectiveness were first presented and published. Furthermore, patients who were transferred-in took over an hour longer to get treated by EVT as calculated from the time the patient was last known normal to EVT initiation. Although transferin patients were moved from the emergency department door to EVT faster than those arriving directly, the door-to-EVT initiation times for the 2 groups still exceeded an hour (68 minutes for transfer versus 128 minutes for direct).
the past two decades since the development of comprehensive stroke centers and the increasing complexity of optimal management for patients with the most severe strokes. Transfer-in patients now represent the majority of inpatients in the stroke units and neurology intensive care units at most comprehensive stroke centers. Transferring patients from one hospital to another is not a simple or quick process. In other studies, interhospital transport delayed EVT by 95 to 109 minutes.
11-14 Every 4-minute faster start of EVT is associated with a lower degree of 90-day disability for 1 of 100 treated patients. Mistriage is associated with an absolute 8% lower freedom from disability and an absolute 9% lower functional independence.
Not surprisingly, Shah et al 10 found that transfers were associated with worse outcome. This had also been found in other studies. [11] [12] [13] [14] What is unusual about the findings of Shah et al 10 is that worse outcome was seen in transfer-in patients even after controlling for the delay in initiating EVT. The explanation for this finding is not clear. Transfer-in patients more often arrived during off hours compared with direct-admit patients that might have affected their management and outcomes. Although similar in most variables affecting outcome, the transfer-in and direct-admit patients in the Shah et al study 10 were not prospectively identified and randomized and so might have differed in some unmeasured respects that could have affected outcome. It is also possible that the transfer process itself may be harmful. For instance, patients with large-vessel occlusion may deteriorate because of hemodynamic or respiratory complications during transfer. The take-home message of these findings is that the current process of relying on interhospital transfer for patients to receive EVT needs to be re-examined.
The results of Shah et al 10 highlight the following important issues that need to be addressed: (1) Door-to-EVT initiation times range from 1 to 2 hours, which is much slower than for ST-segment-elevation myocardial infarction, which is a comparable clinical emergency. There is much room for improvement in this metric. (2) Most patients still receive tPA (tissue-type plasminogen activator) before EVT. Developing prehospital triage algorithms that maximize identification of appropriate candidates for tPA and EVT and minimize delays to receiving both treatments represents another major focus of improving stroke systems of care. One solution, using mobile stroke units to treat patients with tPA in the field and identify EVT candidates and triage them to the nearest appropriate center, is one solution under evaluation. 15 (3) Finally, we need to improve on the current system of transferring patients from one hospital to an EVT center as is the current process described by Shah et al 10 One solution is having patients with the most severe strokes bypass the closest hospital and non-EVT-capable primary stroke centers and be directly routed to an EVT-capable center. However, this is not the only solution and probably not the best one. In addition to the time delay, another reason is that current stroke scales and other nonimaging methods for detecting largevessel occlusion patients in the prehospital space are inexact, so that any triage decisions made in the field by Emergency Medical Services or even by vascular neurology specialists are likely to exclude a portion of patients who might benefit from EVT. An alternative solution is to make more primary stroke centers EVT-capable by spreading the distribution of endovascular expertise. Acute stroke treatment is too time-sensitive for the current hierarchical stroke center system. That was the lesson learned from tPA-treatment rates and speed only improved when all stroke centers were required to give it and give it quickly. So instead of moving patients to the EVT center, perhaps we should move the EVT centers to the patient. This might mean having two tiers of EVT centers. Further research is needed to determine the minimum requirements, training, and procedures needed to achieve good EVT outcomes. Also, is it better to try to orchestrate systematic change of an innovation when it is going through rapid growth like EVT, or after its growth plateaus? Finally, will the optimal distribution of such centers be determined by a top-down or market-driven process? Here, the cardiology community has an opportunity to inform the stroke community by its experience disseminating percutaneous coronary intervention and other effective interventions. 
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